<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>The Avestagenome Project® and &#039;Longevity India&#039; Initiative of Indian Institute of Science (IISc) Sign Landmark Agreement</title>
    <link>https://www.taxtmi.com/news?id=55175</link>
    <description>Avestagenome Project and Longevity India, IISc will jointly design and execute multidisciplinary research using a deeply annotated Biobank and multi omics datasets alongside advanced laboratory infrastructure to pursue two initial projects: integrating whole genome sequencing with lipidomic profiling to identify cardiovascular risk biomarkers, and studying mitochondrial dysfunction with screening of proprietary plant based compounds plus epigenetic profiling to develop therapeutics for age related diseases; anticipated outputs include diagnostics, AI risk models, publications, intellectual property and translational pilot projects.</description>
    <language>en-us</language>
    <pubDate>Wed, 10 Sep 2025 11:01:03 +0530</pubDate>
    <lastBuildDate>Wed, 10 Sep 2025 11:01:04 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=849414" rel="self" type="application/rss+xml"/>
    <item>
      <title>The Avestagenome Project® and &#039;Longevity India&#039; Initiative of Indian Institute of Science (IISc) Sign Landmark Agreement</title>
      <link>https://www.taxtmi.com/news?id=55175</link>
      <description>Avestagenome Project and Longevity India, IISc will jointly design and execute multidisciplinary research using a deeply annotated Biobank and multi omics datasets alongside advanced laboratory infrastructure to pursue two initial projects: integrating whole genome sequencing with lipidomic profiling to identify cardiovascular risk biomarkers, and studying mitochondrial dysfunction with screening of proprietary plant based compounds plus epigenetic profiling to develop therapeutics for age related diseases; anticipated outputs include diagnostics, AI risk models, publications, intellectual property and translational pilot projects.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Wed, 10 Sep 2025 11:01:03 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=55175</guid>
    </item>
  </channel>
</rss>